Primer pairs used for amplification of fragments are written above the panels and indicated by the arrows in Figure 4A and 4B. 
Supplemental Text 1
When normalizing values of amplified cDNA to values obtained by amplification of genomic DNA with the same primer pair using RT-DqPCR, we have to consider the molar ratio between the two compared genes. If we are comparing genes present on two homologous chromosomes their molar ratio in DNA is one. Also, the molar ratio between PP5* or UBA2* gene and Rev gene in DNA is 1 ( Figure 2D ). However, the molar ratio between a sequence present solely in PP5* allele (spanning PP5*/5'LTR junction) and PP5 exon 8, which is present on two chromosomes, is 1:2 ( Figure S2 ). Thus, we have to multiply by 2 all values obtained with normalization of amplified PP5 exon 8 from cDNA to amplification of equal amounts of DNA.
Supplemental Text 2
By determining the ratio between transcripts containing LTR and those containing Rev or Env, we are measuring a sum of the viral (b) and host-viral chimeric transcripts (*mRNA; a) divided by the viral transcripts. This ratio can therefore be expressed as the following equation R=(a+b)/b. If there is no transcription originating from the host promoter and ensuing through the 5'LTR and consequently, no *mRNA (a=0), then the ratio is 1. Additionally, the ratio can be close to 1 when the viral transcription is much larger than the host transcription.
In the case of a known ratio between the viral and host-viral chimeric transcripts, that is between a and b, we can simplify the equation. Thus, if levels of viral transcripts (b) are x-times larger than those of *mRNA (a), the equation is: R=(x+1)/x or R=1+1/x. This is a rational function, which in a diagram (x levels on x-axis and R levels on y-axis) gives us a hyperbolic curve with R-levels approaching to infinity as x levels approach to 0 and R-levels infinitely approaching to 1 with increasing x-levels, thus y-axis and a parallel to x-axis at 1 are asymptotes:
For example, in TNF-α-treated J-Lat 15.4 cells (20% of active viral transcription), Rev mRNA/*mRNA ratio is about 10 ( Figure 2D, bar 4) . In other words, levels of viral mRNA are 10-times larger than those of *mRNA. In this case, R=10+1/10, which is close to 1. If we halve this value (10% of active viral transcription and Rev mRNA/*mRNA ratio 5), then R=5+1/5, which is 1.2. If we halve the last value (5% of active viral transcription and Rev mRNA/*mRNA ratio 2.5), then R=2.5+1/2.5, which is 1.4. At 2% of active viral transcription Rev mRNA/*mRNA ratio is 1 and R=1+1/1, which is 2. Our diagram ( Figures 3B and S3A ) behaves accordingly to the equation, which proves the accuracy of the method. Also, the approach we used to mimic different activation of viral transcription ( Figures 3B and S3A , percentage of GFP+) by mixing cDNA of untreated with cDNA of TNF-α-treated cells gave us precise results, which can be clearly seen by comparing LTR/Rev mRNA values in Figure 3B to those calculated from the equation R=x+1/x, where the starting point is Rev mRNA/*mRNA ratio (~10) for 20% of activated cells ( Figure 2D, bar 4) .
In HIV-infected primary CD4+ T cells, most likely more than 2% of the infected cells were activated as determined by p24 levels. The accuracy of the method and LTR/Rev mRNA ratio 2 in these cells suggests that levels of transcription upstream of the 5'LTR are significant in HIVinfected PBLs.
Notably, to exclude amplification of putative antisense transcripts (Landry et al., 2006) using the above method, we performed reverse transcription with an HIV-specific reverse primer (H17 ,   Table S1 ). In ChIP assay, anti-mouse IgM was added to the samples with anti-PS2-RNAPII and anti-PS2-RNAPII antibodies 2 hours before adding the Protein A Agarose/Salmon Sperm DNA beads (Upstate).
Supplemental References
Landry, S., Halin, M., Lefort, S., Audet, B., Vaquero, C., Mesnard, J.M., and Barbeau, B. (2007) . Detection, characterization and regulation of antisense transcripts in HIV-1. Retrovirology 4,71-86.
